跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Ultramino - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Ultramino
Approved
STANDARD
Ultramino
Shijiazhuang No.4 Pharmaceutical Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
caff48dfa88f7de4
Company
Shijiazhuang No.4 Pharmaceutical Co., Ltd.
Type
Standard
Approval Details
Approval Id
caff48dfa88f7de4
Drug Approval Philippines Name
Ultramino
Product Name
Ultramino
Registration Number
DRP-8399-01
Brand Name
Ultramino
Generic Name
Amino Acid + Sorbitol
Dosage Form
Solution for Intravenous Infusion
Dosage Strength
Formulation: Each 100 mL contains: Glycine 760 mg L-Phenylalanine 533 mg L-Arginine Hydrochloride L-Leucine L-Lysine Hydrochloride 430 mg L-Valine 360 mg L-Isoleucine 352 mg L-Aspartic Acid L-Histidine Hydrochloride 250 mg L-Threonine 500 mg 490 mg L-Methionine L-Alanine L-Proline L-Serine L-Tryptophan L-Glutamic Acid L-Tyrosine L-Cystine Sorbitol 225 mg 200 mg 100 mg 100 mg 90 mg 75 mg 25 mg 10 mg 250 mg 5 mg 250 mg
Manufacturer
Shijiazhuang No.4 Pharmaceutical Co., Ltd.
Importer
Sahar International Trading, Inc.
Distributor
Ellebasy Medicale Group Inc.
Issuance Date
29 February 2024
Expiry Date
20 March 2029
Pharmacologic Category
Total Parenteral Nutrition
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
caff48dfa88f7de4
Type
Standard
Back to Philippines FDA Approvals